FUSION ANTIBODIES PLC

Active Belfast

Research and experimental development on biotechnology

24 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.
F

FUSION ANTIBODIES PLC

Research and experimental development on biotechnology

Founded 29 Nov 2000 Active Belfast, Northern Ireland 24 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther professional, scientific and technical activities n.e.c.

Previous Company Names

FUSION ANTIBODIES LIMITED 29 Nov 2000 — 11 Dec 2017
Accounts Submitted 10 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 10 Feb 2026 Next due 3 Feb 2027 9 months remaining
Net assets £669K £1M 2024 year on year
Total assets £1M £1M 2024 year on year
Total Liabilities £654K £27K 2024 year on year
Charges 5
2 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

1 Springbank Road Springbank Industrial Estate Belfast BT17 0QL Northern Ireland

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for FUSION ANTIBODIES PLC (NI039740), an active life sciences and medical technology company based in Belfast, Northern Ireland. Incorporated 29 Nov 2000. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£359.00k

Decreased by £840.00k (-70%)

Net Assets

£669.00k

Decreased by £1.12M (-63%)

Total Liabilities

£654.00k

Increased by £27.00k (+4%)

Turnover

£1.97M

Increased by £824.00k (+72%)

Employees

24

Decreased by 7 (-23%)

Debt Ratio

49%

Increased by 23 (+88%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

30 Allotments 110,772,670 Shares £94491.56m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jan 202611,365,625£1.48m£1.48m
12 May 2025338,113£21k£0.061
9 Apr 20258,416,020£568k£568k
21 Mar 20258,949,208£604k£604k
7 Mar 202434,375,000£1.38m£0.04

Officers

Officers

1 active 2 resigned
Status
Stephen Barry SmythSecretaryUnknownUnknown16 Sept 2023Active

Shareholders

Shareholders (23)

The Bank Of New York (nominees) Limited
10.8%
Rathbone Nominees Limited
7.7%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

FUSION ANTIBODIES PLC Current Company

Charges

Charges

2 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Feb 2026CapitalAllotment of shares (GBP 5,000,875.12) on 2026-01-30
10 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-20 with no updates
29 Oct 2025ResolutionResolutions
15 Oct 2025AuditorsAuditors Resignation Company
10 Sept 2025AccountsAnnual accounts made up to 2025-03-31
11 Feb 2026 Capital

Allotment of shares (GBP 5,000,875.12) on 2026-01-30

10 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-20 with no updates

29 Oct 2025 Resolution

Resolutions

15 Oct 2025 Auditors

Auditors Resignation Company

10 Sept 2025 Accounts

Annual accounts made up to 2025-03-31

Recent Activity

Latest Activity

Allotment of shares (GBP 5,000,875.12) on 2026-01-30

2 months ago on 11 Feb 2026

Confirmation statement made on 2026-01-20 with no updates

2 months ago on 10 Feb 2026

Resolutions

5 months ago on 29 Oct 2025

Auditors Resignation Company

6 months ago on 15 Oct 2025

Annual accounts made up to 2025-03-31

7 months ago on 10 Sept 2025